These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8403559)

  • 41. Prevention of cancer cachexia by a novel nuclear factor {kappa}B inhibitor in prostate cancer.
    Kuroda K; Horiguchi Y; Nakashima J; Kikuchi E; Kanao K; Miyajima A; Ohigashi T; Umezawa K; Murai M
    Clin Cancer Res; 2005 Aug; 11(15):5590-4. PubMed ID: 16061877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trophoblastic cell lines generated from tumour necrosis factor receptor-deficient mice reveal specific functions for the two tumour necrosis factor receptors.
    Rasmussen CA; Pace JL; Banerjee S; Phillips TA; Hunt JS
    Placenta; 1999; 20(2-3):213-22. PubMed ID: 10195744
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacodynamic effects of the murine p75-Fc fusion protein in mice.
    Hu YL; Kim HY; Kohno T; Khare SD
    J Investig Dermatol Symp Proc; 2007 May; 12(1):50-1. PubMed ID: 17502871
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Production of recombinant TRAIL and TRAIL receptor: Fc chimeric proteins.
    Schneider P
    Methods Enzymol; 2000; 322():325-45. PubMed ID: 10914028
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term etanercept therapy favors weight gain and ameliorates cachexia in rheumatoid arthritis patients: roles of gut hormones and leptin.
    Chen CY; Tsai CY; Lee PC; Lee SD
    Curr Pharm Des; 2013; 19(10):1956-64. PubMed ID: 23305268
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular analysis of the cytokine network involved in cachexia in colon 26 adenocarcinoma-bearing mice.
    Yasumoto K; Mukaida N; Harada A; Kuno K; Akiyama M; Nakashima E; Fujioka N; Mai M; Kasahara T; Fujimoto-Ouchi K
    Cancer Res; 1995 Feb; 55(4):921-7. PubMed ID: 7850809
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of NF-kappaB and cytokine in experimental cancer cachexia.
    Zhou W; Jiang ZW; Tian J; Jiang J; Li N; Li JS
    World J Gastroenterol; 2003 Jul; 9(7):1567-70. PubMed ID: 12854165
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor necrosis factor (TNF)-alpha-induced interleukin-8 in human blood cultures discriminates neutralization by the p55 and p75 TNF soluble receptors.
    Frishman JI; Edwards CK; Sonnenberg MG; Kohno T; Cohen AM; Dinarello CA
    J Infect Dis; 2000 Dec; 182(6):1722-30. PubMed ID: 11069245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumour.
    Mahony SM; Beck SA; Tisdale MJ
    Br J Cancer; 1988 Apr; 57(4):385-9. PubMed ID: 3390373
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.
    Ashkenazi A; Marsters SA; Capon DJ; Chamow SM; Figari IS; Pennica D; Goeddel DV; Palladino MA; Smith DH
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10535-9. PubMed ID: 1660140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protein turnover in skeletal muscle of tumour-bearing transgenic mice overexpressing the soluble TNF receptor-1.
    Llovera M; García-Martínez C; López-Soriano J; Agell N; López-Soriano FJ; Garcia I; Argilés JM
    Cancer Lett; 1998 Aug; 130(1-2):19-27. PubMed ID: 9751252
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A mouse model of lung injury induced by microbial products: implication of tumor necrosis factor.
    Denis M; Guojian L; Widmer M; Cantin A
    Am J Respir Cell Mol Biol; 1994 Jun; 10(6):658-64. PubMed ID: 8003342
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice.
    Rothstein JL; Schreiber H
    Proc Natl Acad Sci U S A; 1988 Jan; 85(2):607-11. PubMed ID: 3422444
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The pharmacology study of a new recombinant TNF receptor-hyFc fusion protein.
    Lee JH; Cho JH; Yeo J; Lee SH; Yang SH; Sung YC; Kang JH; Park CS
    Biologicals; 2013 Mar; 41(2):77-83. PubMed ID: 23190454
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Soluble tumor necrosis factor receptor: inhibition of human immunodeficiency virus activation.
    Howard OM; Clouse KA; Smith C; Goodwin RG; Farrar WL
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2335-9. PubMed ID: 7681592
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IL-2 receptor-targeted cytolytic IL-2/Fc fusion protein treatment blocks diabetogenic autoimmunity in nonobese diabetic mice.
    Zheng XX; Steele AW; Hancock WW; Kawamoto K; Li XC; Nickerson PW; Li Y; Tian Y; Strom TB
    J Immunol; 1999 Oct; 163(7):4041-8. PubMed ID: 10491008
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
    Corcoran AE; Scallon BJ; Trinh H; Chernajovsky Y; Ghrayeb J; Feldmann M
    Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice.
    Wooley PH; Dutcher J; Widmer MB; Gillis S
    J Immunol; 1993 Dec; 151(11):6602-7. PubMed ID: 8245488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Infrequent delivery of a long-acting PTH-Fc fusion protein has potent anabolic effects on cortical and cancellous bone.
    Kostenuik PJ; Ferrari S; Pierroz D; Bouxsein M; Morony S; Warmington KS; Adamu S; Geng Z; Grisanti M; Shalhoub V; Martin S; Biddlecome G; Shimamoto G; Boone T; Shen V; Lacey D
    J Bone Miner Res; 2007 Oct; 22(10):1534-47. PubMed ID: 17576164
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice.
    Brånén L; Hovgaard L; Nitulescu M; Bengtsson E; Nilsson J; Jovinge S
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2137-42. PubMed ID: 15345516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.